Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/12210
Title: A Rapid Molecular Detection Tool for Toxigenic M1UK  Streptococcus pyogenes
Authors: Brouwer, S.;Das, S.;Hayes, A. J.;Bertolla, O. M.;Davies, M. R.;Walker, M. J.;Whiley, D. M.;Irwin, A. D. ;Tickner, J. A.
Issue Date: 2025
Source: J Infect Dis, 2025 (231) 2 p.e375-e384
Pages: e375-e384
Journal Title: J Infect Dis
Abstract: BACKGROUND: The gradual replacement of the Streptococcus pyogenes M1global genotype by a newly emergent M1UK variant is a global public health threat warranting increased surveillance. M1UK differs from progenitor M1global genotype by 27 single-nucleotide polymorphisms and is characterized by increased speA superantigen expression in vitro. METHODS: An allele-specific real-time polymerase chain reaction assay was developed for the rapid detection of M1UK strains. The assay was used in combination with whole genome sequencing to determine emm (sub)type distribution for 51 invasive (n = 9) and noninvasive (n = 42) S pyogenes clinical isolates. RESULTS: Emm1 was the most prevalent S pyogenes emm serotype (n = 11) in this set of clinical isolates, with M1UK being the dominant emm1 genotype (4/5 invasive, 3/6 noninvasive isolates). The assay accurately detected M1UK strains. Whole genome sequencing revealed continued presence of Australian M1UK sublineages associated with epidemic scarlet fever-causing S pyogenes in Asia. CONCLUSIONS: Our study establishes a suitable target for detection of the toxigenic M1UK and confirms the maintenance of M1UK strains in Queensland, Australia. This assay can be deployed in laboratories and provides a valuable, cost-effective tool to enhance surveillance of the expanding M1UK clone.
DOI: 10.1093/infdis/jiae437
Appears in Sites:Children's Health Queensland Publications
Queensland Health Publications

Show full item record

Page view(s)

80
checked on Oct 6, 2026

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.